Thetis Pharmaceuticals Receives $1,500,000 New Financing

  • Feed Type
  • Date
    8/22/2011
  • Company Name
    Thetis Pharmaceuticals
  • Mailing Address
    167 Old Post Rd Southport, CT 06890
  • Company Description
    The company is developing treatments for for diabetes-related diseases.
  • Website
    Undisclosed
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $1,500,000
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    The company expects to begin clinical studies with TP101 in 2012, an exceptionally rapid timeline made possible by certain regulatory efficiencies associated with the metformin / omega-3 chemical composition of the drug candidate.
  • M&A Terms
  • Venture Investor
    Connecticut Innovations
  • Venture Investor
    Stonehenge Capital
  • Venture Investor
    Undisclosed

By posting a comment, you agree to our terms and conditions.